0001209191-23-017233.txt : 20230308 0001209191-23-017233.hdr.sgml : 20230308 20230308170042 ACCESSION NUMBER: 0001209191-23-017233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conner Edward R. CENTRAL INDEX KEY: 0001691265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41498 FILM NUMBER: 23716865 MAIL ADDRESS: STREET 1: 501 CANAL BLVD. STREET 2: POINT RICHMOND TECH CENTER CITY: RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Third Harmonic Bio, Inc. CENTRAL INDEX KEY: 0001923840 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 834553503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1700 MONTGOMERY STREET STREET 2: SUITE 210 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 2097272457 MAIL ADDRESS: STREET 1: 1700 MONTGOMERY STREET STREET 2: SUITE 210 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-06 0 0001923840 Third Harmonic Bio, Inc. THRD 0001691265 Conner Edward R. 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 8.61 2023-03-06 4 D 0 383288 D 2032-07-27 Common Stock 383288 0 D Employee Stock Option (right to buy) 4.20 2023-03-06 4 A 0 383288 A 2032-07-27 Common Stock 383288 383288 D Employee Stock Option (right to buy) 18.40 2023-03-06 4 D 0 95000 D 2032-10-24 Common Stock 95000 0 D Employee Stock Option (right to buy) 4.20 2023-03-06 4 A 0 95000 A 2032-10-24 Common Stock 95000 95000 D Employee Stock Option (right to buy) 4.20 2023-03-06 4 A 0 137000 0.00 A 2033-03-05 Common Stock 137000 137000 D The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. 25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. /s/ Robert Ho, Attoney-in-Fact 2023-03-08